Skip to Main Content

Allergic rhinitis is a chronic inflammatory disease of the upper airway caused by IgE sensitization to airborne allergens in genetically susceptible individuals. In the United States, symptoms of allergic rhinoconjunctivitis (ARC) affect between 20% to 30% of adults and as many as 40% of children. The clinical presentation characteristically is associated with frequent sneezing, nasal congestion, and nasal discharge. The vast majority of patients with allergic rhinitis complain or display ocular symptoms (ie, itchy/watery eyes), thus it is termed allergic rhinoconjunctivitis, for which it is better known. Involvement of the lower airway is frequent: up to 40% of patients with ARC also suffer from asthma, and most show evidence of bronchial hyperreactivity. Allergic rhinitis can affect the child’s quality of life and can be associated with conditions such as sleep disturbances and learning difficulties.

Allergic rhinitis has been subdivided into seasonaland perennial types based on time and duration of symptom occurrence. Seasonal symptoms that only occur in spring and summer are often referred to as classical hay fever (pollinosis), whereas perennial allergic rhinitis is caused by an allergic response to allergens such as dust mites and pet dander that are present throughout the year.

There is a wide variation in the prevalence of allergic rhinoconjunctivitis (ARC) worldwide.1 In the pediatric age, the numbers range from 0.8% to 14.9% in 6 to 7 year olds and from 1.4% to 39.7% in 13 to 14 year olds. The reasons behind these disparities are not completely understood, but both environmental and genetic factors are likely to play a role. Like other allergic diseases, the prevalence of ARC seems to be on the rise, particularly in industrialized countries, and as such, ARC has been named a “disease of civilization.” Risks factors for allergic rhinitis include family history of atopy, higher socienoconomic class, and evidence of sensitization.

Aeroallergen sensitization may occur within the first 2 years of life, especially in children with a family history of atopy, but classical symptoms of seasonal allergic rhinitis generally do not develop until 2 to 7 years of age.

In childhood, allergic rhinitis is more frequent in boys, but in adults it is more frequent in women. The prevalence of seasonal allergic rhinitis is higher in children and adolescents, whereas perennial allergic rhinitis has a higher prevalence in adults.

The pathogenesis of allergic rhinoconjunctivitis (ARC) responds to the same immune mechanisms as other allergic disorders. In this case, exposure to airborne allergens, in a genetically susceptible individual, initiates the series of events that lead to the local activation of allergen-specific T cells with a TH2 bias that direct the production of inflammatory cytokines, chemokines, and allergen-specific IgE.3 Upon reexposure to the same allergen, cross-liking of FceR-bound IgE on the surface of mast cells triggers the release of preformed mediators. Histamine released by mast cells is largely responsible for the immediate symptoms associated with ARC such as sneezing, itching, ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.